ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study
Abstract Background Non‐small cell lung cancer (NSCLC) is the predominant lung cancer subtype with high mortality rate. Drug resistance and immune evasion limit its therapeutic outcomes. Specific mechanism of the oncogenic ZFP36L1 in NSCLC remains unclear. Methods scRNA‐seq data were analysed using...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2026-04-01
|
| Serija: | Clinical and Translational Medicine |
| Teme: | |
| Online pristup: | https://doi.org/10.1002/ctm2.70642 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|